Suvrat Pharmaceuticals Private Limited
Pharmaceutical company setting up plant for active ingredients, promoted by Kamlapurkar family.
2006 | Thane, Maharashtra (India) | Active
Suvrat Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 3.00 Cr
- Paid Up Capital ₹ 1.51 Cr
- Company Age 19 Year, 15 Days
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 8.50 Cr
- Revenue Growth -9.09%
- Profit Growth -42.86%
- Ebitda -48.66%
- Net Worth 0.31%
- Total Assets 5.59%
About Suvrat Pharmaceuticals
Suvrat Pharmaceuticals Private Limited (SPPL) is a Private Limited Indian Non-Government Company incorporated in India on 06 March 2006 and has a history of 19 years. Its registered office is in Thane, Maharashtra, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 3.00 Cr and a paid-up capital of Rs 1.51 Cr.
The company has closed loans amounting to ₹8.50 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Pravin Kamalapurkar and Rupali Kamalapurkar serve as directors at the Company.
Company Details
- Location
Thane, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U24231MH2006PTC160298
- Company No.
160298
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
06 Mar 2006
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Pharma
Suvrat Pharmaceuticals Private Limited
Explore comprehensive data for Suvrat Pharmaceuticals Private Limited, including financials, compliance details, shareholding patterns, and litigation history.
Who are the key members and board of directors at Suvrat Pharmaceuticals?
Executive Team (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Pravin Kamalapurkar  | Managing Director | 06-Mar-2006 | Current |
| Rupali Kamalapurkar | Managing Director | 06-Mar-2006 | Current |
Board Members
No Directors or KMP associated with company. Upon reviewing the records, we can confirm that there are no Directors or Key Management Personnel (KMP) associated with this company at present.
Financial Performance of Suvrat Pharmaceuticals.
Suvrat Pharmaceuticals Private Limited, for the financial year ended 2018, experienced Minor drop in revenue, with a 9.09% decrease. The company also saw a substantial fall in profitability, with a 42.86% decrease in profit. The company's net worth moved up by a moderate rise of 0.31%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Suvrat Pharmaceuticals?
In 2018, Suvrat Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
Open Charges
₹0
Satisfied Charges
₹8.50 Cr
Charges Breakdown by Lending Institutions
- State Bank Of Hyderabad : 8.50 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 24 Dec 2014 | State Bank Of Hyderabad | ₹8.50 Cr | Satisfied |
How Many Employees Work at Suvrat Pharmaceuticals?
Unlock and access historical data on people associated with Suvrat Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Suvrat Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Suvrat Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Latest Updates, News, and FAQs on Suvrat Pharmaceuticals
Recent activity within the organization
- Annual General Meeting
Suvrat Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
- Balance Sheet
Suvrat Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai.
- Charges
A charge registered on 24 Dec 2014 via Charge ID 10544036 with State Bank Of Hyderabad was fully satisfied on 21 Oct 2023.
- Charges
A charge with State Bank Of Hyderabad of Rs. 8.50 Cr registered on 24 Dec 2014 with Charge ID 10544036 was modified on 21 Oct 2015.
- Charges
A charge with State Bank Of Hyderabad amounted to Rs. 8.50 Cr with Charge ID 10544036 was registered on 24 Dec 2014.
- Director Appointment
Pravin Prabhakarrao Kamalapurkar was appointed as a Managing Director was appointed as a Managing Director on 06 Mar 2006 & has been associated with this company since 19 years 15 days .
Frequently asked questions
What is the Incorporation or founding date of Suvrat Pharmaceuticals Private Limited?
Suvrat Pharmaceuticals Private Limited was incorporated on 06 Mar 2006.
What is authorized share capital and paid-up capital of Suvrat Pharmaceuticals Private Limited?
The authorized share capital of Suvrat Pharmaceuticals Private Limited is ₹ 3.00 Cr and paid-up capital is ₹ 1.51 Cr.
Who are the current board members & directors of Suvrat Pharmaceuticals Private Limited?
Currently 2 directors are associated with Suvrat Pharmaceuticals Private Limited.
- Pravin Prabhakarrao Kamalapurkar
- Rupali Pravin Kamalapurkar
What is the registered address of Suvrat Pharmaceuticals Private Limited?
As per Ministry of Corporate Affairs (Mca), the registered address of Suvrat Pharmaceuticals Private Limited is Room No. 1A Ground Floor Vilas Apartment Sant Tukaram Path Kopri Opp. Mirani Na Gar, India, Thane East, Maharashtra, 400603.
What is the corporate identification number (CIN) and company number of Suvrat Pharmaceuticals Private Limited?
The corporate identification number (CIN) of Suvrat Pharmaceuticals Private Limited is U24231MH2006PTC160298 and the company number is 160298 as per Ministry of Corporate Affairs (MCA).
What has been the recent revenue trend for Suvrat Pharmaceuticals Private Limited?
According to the financial reports for the fiscal year 2018, the revenue trend for Suvrat Pharmaceuticals Private Limited has fallen by -9.09%.
What change has been observed in the net worth of Suvrat Pharmaceuticals Private Limited, and by what percentage?
The financial reports for the fiscal year 2018 indicates that The net worth of Suvrat Pharmaceuticals Private Limited has experienced an upsurge of 0.31%.
When was the last Balance Sheet of Suvrat Pharmaceuticals Private Limited filed with the ROC?
The most recent Balance Sheet for Suvrat Pharmaceuticals Private Limited was filed with the ROC on 31 Mar 2024.
Unlock Business Insights – Explore Instantly!
Search company & director profiles for free and gain access to critical business data.
- 3.1M+ Companies
- 15M+ Legal Cases
- 525K+ Credit Ratings
- 5.8M+ Directors & KMP
- 750K+ Regulatory Alerts
- 1.1M+ Companies' Financial Records